v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Operating activities:    
Net loss $ (13,142) $ (11,443)
Adjustments to reconcile net loss to net cash flows used in operating activities:    
Depreciation of property and equipment 47 91
Interest income and unrealized gains from marketable securities, net (1)
Share-based compensation 1,057 1,349
Changes in assets and liabilities:    
Inventory (584)
Prepaid expenses and other assets (182) 69
Accounts payable and accrued liabilities 495 873
Change in long-term deposit (737)
Insurance recovery related to legal settlement and legal expenses received in cash 1,335
Legal settlement paid in cash (1,100)
Net cash flows used in operating activities (13,046) (8,827)
Investing activities:    
Purchase of property and equipment (60) (25)
Proceeds from maturities of marketable securities 2,500
Purchase of marketable securities (82,926) (5,120)
Proceeds from sales of marketable securities 10,602 4,182
Net cash flows (used in) provided by investing activities (72,384) 1,537
Financing activities:    
Issuance of common stock and warrants, net of issuance costs 86,239 7,936
Exercise of options 1
Net cash flows provided by financing activities 86,240 7,936
Increase in cash, cash equivalents and restricted cash 810 646
Cash, cash equivalents and restricted cash at beginning of year 3,163 2,517
Cash, cash equivalents and restricted cash at ending of year 3,973 3,163
Supplemental disclosure of non-cash investing and financing activities:    
Issuance costs not paid 101
Legal settlement settled through issuance of common stock 1,111
Right-of-use assets obtained in exchange for lease liabilities 893 98
Accrued bonus settled through grant of stock-option awards 76
Deferred issuance costs $ 30